Teleflex TFX recently announced the upcoming full market release of the Advanced Tissue Control (“ATC”) feature on its unified UroLift 2 System — a platformdesigned for the treatment of benign ...
Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...
Teleflex announces favorable results for UroLift™ in treating BPH, showing higher patient satisfaction and better early recovery compared to Rezūm. Teleflex Incorporated announced new results from the ...
The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.
In a ground-breaking medical achievement, Nigeria has become the first country in West and Central Africa to successfully perform the UroLift procedure, a revolutionary treatment for benign prostate ...
A consultant urological, laparoscopic, and robotic surgeon, Professor Kingsley Ekwueme, has successfully performed West Africa's first UroLift procedure, a new minimally invasive treatment for ...
On Nov 16, we issued an updated research report on Teleflex Incorporated TFX. The company continues to report strong growth in UroLift. However, escalating costs and expenses remain a major cause of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback